Sanofi to restructure Newton diabetes startup Onduo, saying it ‘over-invested’

Sanofi’s new CEO laid out plans Tuesday to shake up one of the Bay State’s biggest drug companies, potentially throwing its 3-year-old diabetes-focused startup Onduo for a loop.